SEC Info - Morgan Stanley - ‘SC 13G/A’ on 3/9/20 re: Aclaris Therapeutics, Inc.

SEC Info℠

Home

Help

Please Sign In

Morgan Stanley – ‘SC 13G/A’ on 3/9/20 re: Aclaris Therapeutics, Inc.

On: Monday, 3/9/20, at 4:10pm ET · Accession #: 895421-20-278 · File #: 5-89137

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer

 3/09/20  Morgan Stanley                    SC 13G/A               1:15K  Aclaris Therapeutics, Inc.

Amendment to Statement of Acquisition of Beneficial Ownership by a Passive Investor — Sch. 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Ms Amendment                                           8     21K

Filing Submission 0000895421-20-000278 – SGML Text

Original SGML Text submitted by:	Morgan Stanley

To view the SGML, please refresh
this page.

↑Top

Morgan Stanley – ‘SC 13G/A’ on 3/9/20 re: Aclaris Therapeutics, Inc.

On: Monday, 3/9/20, at 4:10pm ET · Accession #: 895421-20-278 · File #: 5-89137

Previous ‘SC 13G’: ‘SC 13G/A’ on 3/9/20 · Next: ‘SC 13G’ on 3/16/20 · Latest: ‘SC 13G/A’ on 4/5/24

Amendment to Statement of Acquisition of Beneficial Ownership by a Passive Investor — Sch. 13GFiling Table of Contents

To view the SGML, please refresh this page.

Amendment to Statement of Acquisition of Beneficial Ownership by a Passive Investor — Sch. 13G
Filing Table of Contents

To view the SGML, please refresh
this page.